We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Advanced Medical Solutions Group plc (AMS) Ordinary 5p

Sell:235.50p Buy:236.50p 0 Change: No change
FTSE AIM 100:0.60%
Market closed Prices as at close on 19 July 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:235.50p
Buy:236.50p
Change: No change
Market closed Prices as at close on 19 July 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:235.50p
Buy:236.50p
Change: No change
Market closed Prices as at close on 19 July 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Advanced Medical Solutions Group plc is a United Kingdom-based independent developer and manufacturer of tissue-healing technology, focused on quality outcomes for patients. Its surgical products, including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, Peters Surgical, Ifabond, Vitalitec and Seal-G. It also supplies wound care dressings, such as silver alginates, alginates and foams through its ActivHeal brand, and under white label. Its Surgical Business Unit includes tissue adhesives, sutures, biosurgical devices and internal fixation devices. The Woundcare Business Unit comprises a multi-product portfolio of advanced wound care dressings and a portfolio of specialist medical bulk materials and multi-layer wound care products. Its products are manufactured in the United Kingdom, Germany, France, the Netherlands, Thailand, India, the Czech Republic and Israel.

Contact details

Address:
Premier Park, 33 Road One
WINSFORD
CW7 3RT
United Kingdom
Telephone:
+44 (01606) 863500
Website:
https://www.admedsol.com/

Important dates

Future events
There are no future events available.
Past events
Final dividend payment date 21 June 2024 21/06/24
AGM 12 June 2024 12/06/24
General meeting 10 June 2024 10/06/24
Final ex-dividend date 30 May 2024 30/05/24
Annual report 13 May 2024 13/05/24
Final results 13 March 2024 13/03/24
Trading Announcement 10 January 2024 10/01/24
Interim dividend payment date 27 October 2023 27/10/23
Interim ex-dividend date 28 September 2023 28/09/23
Interim results 20 September 2023 20/09/23
Trading Announcement 04 September 2023 04/09/23

General stock information

EPIC:
AMS
ISIN:
GB0004536594
Market cap:
£507.13 million
Shares in issue:
214.43 million
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE AIM 100,FTSE AIM All Share

Key personnel

  • Andrew Meredith
    Chief Executive Officer, Executive Director
  • Eddie Johnson
    Chief Financial Officer, Executive Director
  • Brian Dowd
    Vice President - Corporate Business Development
  • Cathy Tomlinson
    Group Human Resources Director
  • Simon Coates
    IT Director
  • Andy Donnelly
    Group R&D Director
  • Rose Guang
    Group Quality Assurance/Regulatory Affairs (QA/RA) Director
  • Ross McDonald
    Business Unit Director - Surgical
  • Lynaye Reynolds
    Group Quality Director
  • Becky Walmsley
    Business Unit Director - Woundcare

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.